Lyra Therapeutics, Inc. (NASDAQ:LYRA) Receives Average Recommendation of “Hold” from Analysts
Shares of Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) have received a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the […]
Shares of Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Free Report) have received a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the […]